With a turnaround time of less than 7 days per reportable result, a next-generation sequencing service will perform molecular panel testing for invasive colon cancer for under $1,000.
Read More
The GeneStrat test by Biodesix reveals actionable NSCLC mutations, returning results within 72 hours.
Read MorePhase I SBIR grant for sickle cell disease research supported by scientific data recently published in Pediatric Blood & Cancer.
Read MoreA new molecular PCR test identifies KRAS mutations to aid in determining therapy for metastatic colorectal cancer.
Read More
An emerging method of molecular analysis holds significant potential for profiling the tumors where the biomarkers originated, and thereby improving the diagnosis and treatment of cancer and other diseases.
Read More